Microba Life Sciences Limited

ASX:MAP Stock Report

Market Cap: AU$91.8m

Microba Life Sciences Future Growth

Future criteria checks 2/6

Microba Life Sciences wird ein jährliches Wachstum der Gewinne und Einnahmen um 9% bzw. 61.9% prognostiziert, während der Gewinn pro Aktie um 17.3% auf grow steigen dürfte.

Key information

21.4%

Earnings growth rate

32.4%

EPS growth rate

Healthcare earnings growth20.0%
Revenue growth rate58.7%
Future return on equityn/a
Analyst coverage

Low

Last updated17 Mar 2024

Recent future growth updates

Recent updates

We're Hopeful That Microba Life Sciences (ASX:MAP) Will Use Its Cash Wisely

Aug 01
We're Hopeful That Microba Life Sciences (ASX:MAP) Will Use Its Cash Wisely

We're Not Very Worried About Microba Life Sciences' (ASX:MAP) Cash Burn Rate

Apr 28
We're Not Very Worried About Microba Life Sciences' (ASX:MAP) Cash Burn Rate

Is Microba Life Sciences (ASX:MAP) In A Good Position To Invest In Growth?

Jul 05
Is Microba Life Sciences (ASX:MAP) In A Good Position To Invest In Growth?

Earnings and Revenue Growth Forecasts

ASX:MAP - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202634-9N/A-62
6/30/202518-17-12-153
6/30/202412-17-17-152
12/31/20237-18-23-20N/A
9/30/20236-16-19-16N/A
6/30/20235-13-15-12N/A
3/31/20235-12-15-12N/A
12/31/20225-11-14-11N/A
9/30/20225-11-13-11N/A
6/30/20225-11-12-10N/A
3/31/20224-11-11-10N/A
12/31/20214-11-9-9N/A
9/30/20214-9-9-8N/A
6/30/20214-8-8-7N/A
6/30/20203-7-5-4N/A
6/30/20192-5-4-4N/A

Analyst Future Growth Forecasts

Einkommen vs. Sparrate: MAP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: MAP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: MAP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: MAPDie Einnahmen des Unternehmens (57.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (4% pro Jahr).

Hohe Wachstumseinnahmen: MAPDie Einnahmen des Unternehmens (57.4% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.


Earnings per Share Growth Forecasts


Future Return on Equity

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von MAP in 3 Jahren voraussichtlich hoch sein wird


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.